Mary Canning is a Partner at Epidarex Capital with over 15 years in health science commercialization. She previously worked at MRC Technology and Scottish Enterprise, and holds a Ph.D. from the University of Edinburgh.
What Mary can write
Career
- Scottish Enterprise Proof of Concept Programme · oversaw the life science portfolio
- MRC Technology (now LifeArc) · led commercialisation of intellectual property
- Scottish Enterprise Proof of Concept Programme
- Medical Research Council Technology · Business Manager
- Epidarex Capital · AssociateNow
- Epidarex Capital · PartnerNow
Investments named in public bios
Focus
Education
Also at Epidarex Capital
Partners like Mary
At firms with a similar stage, sector and check size.
Alert me when Epidarex Capital is active
One email when Mary's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Mary Canning?
Mary Canning is a Partner at Epidarex Capital with over 15 years in health science commercialization. She previously worked at MRC Technology and Scottish Enterprise, and holds a Ph.D. from the University of Edinburgh.
How much does Mary Canning invest?
Epidarex Capital has not reported a check size. It invests at seed, series a.
How do I pitch Mary Canning?
Email [email protected], the firm's inbox for founders, and name Mary in the subject. A warm intro from a founder Epidarex Capital backed works better.
What did Mary Canning do before Epidarex Capital?
oversaw the life science portfolio at Scottish Enterprise Proof of Concept Programme; led commercialisation of intellectual property at MRC Technology (now LifeArc); Scottish Enterprise Proof of Concept Programme; Business Manager at Medical Research Council Technology.
Last updated 2026-10-15. Is this you? Ask for a correction.